Repolarization Injury and Occurrence of Torsades de Pointes During Acute Takotsubo Syndrome.

QTc prolongation repolarization injury takotsubo cardiomyopathy takotsubo syndrome torsades de pointes

Journal

JACC. Advances
ISSN: 2772-963X
Titre abrégé: JACC Adv
Pays: United States
ID NLM: 9918419284106676

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 17 04 2024
revised: 04 07 2024
accepted: 06 08 2024
medline: 18 9 2024
pubmed: 18 9 2024
entrez: 18 9 2024
Statut: epublish

Résumé

During takotsubo syndrome (TS), QTc prolongation is common, reflecting repolarization injury and providing the substrate for torsades de pointes (TdP). TdP has been reported sporadically in TS, yet QTc prolongation and TdP risk are often overlooked during management. In TS patients, we sought to document TdP incidence, characteristics of patients with TdP, and association of QTc with postdischarge survival. Among consecutive TS patients at a single institution, we documented admission and discharge QTc, TdP incidence, and postdischarge 1-year mortality from 2006 to 2019. For perspective regarding TdP-TS risk, we characterized all published TdP cases from 2003 to 2022. Of 259 patients, median age was 68 (range: 59-77) years; 92% were female. The QTc interval was prolonged (≥460 ms) on admission in 129 (49.8%) patients and at discharge in 140 (54%) patients. QTc was ≥500 ms either on admission or at discharge in 98 (37.8%) patients. In-hospital TdP incidence was 0.8%. Postdischarge mortality was associated with admission but not discharge, QTc: <460 ms (1.6%); 460-499 ms (12.6%); ≥500 ms (8.8%); During TS, QTc ≥500 ms was frequent. TdP incidence was low, with unpredictable occurrence and observed almost entirely with QTc ≥500 ms. A normal admission QTc was associated with >98% survival at 1-year postdischarge.

Sections du résumé

Background UNASSIGNED
During takotsubo syndrome (TS), QTc prolongation is common, reflecting repolarization injury and providing the substrate for torsades de pointes (TdP). TdP has been reported sporadically in TS, yet QTc prolongation and TdP risk are often overlooked during management.
Objectives UNASSIGNED
In TS patients, we sought to document TdP incidence, characteristics of patients with TdP, and association of QTc with postdischarge survival.
Methods UNASSIGNED
Among consecutive TS patients at a single institution, we documented admission and discharge QTc, TdP incidence, and postdischarge 1-year mortality from 2006 to 2019. For perspective regarding TdP-TS risk, we characterized all published TdP cases from 2003 to 2022.
Results UNASSIGNED
Of 259 patients, median age was 68 (range: 59-77) years; 92% were female. The QTc interval was prolonged (≥460 ms) on admission in 129 (49.8%) patients and at discharge in 140 (54%) patients. QTc was ≥500 ms either on admission or at discharge in 98 (37.8%) patients. In-hospital TdP incidence was 0.8%. Postdischarge mortality was associated with admission but not discharge, QTc: <460 ms (1.6%); 460-499 ms (12.6%); ≥500 ms (8.8%);
Conclusions UNASSIGNED
During TS, QTc ≥500 ms was frequent. TdP incidence was low, with unpredictable occurrence and observed almost entirely with QTc ≥500 ms. A normal admission QTc was associated with >98% survival at 1-year postdischarge.

Identifiants

pubmed: 39290821
doi: 10.1016/j.jacadv.2024.101263
pii: S2772-963X(24)00494-0
pmc: PMC11406033
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101263

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

This study was funded by the Penny Anderson Women’s Cardiovascular Science Center at 10.13039/100008171Minneapolis Heart Institute Foundation. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Evangelia Vemmou (E)

Department of Internal Medine, Yale New Haven Hospital, New Haven, Connecticut, USA.

Thomas Basala (T)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Dawn Witt (D)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Ilias Nikolakopoulos (I)

Department of Internal Medine, Yale New Haven Hospital, New Haven, Connecticut, USA.

Seth Bergstedt (S)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Iosif Xenogiannis (I)

Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Robert G Hauser (RG)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Scott W Sharkey (SW)

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Classifications MeSH